From first-time presenters to experienced investigators, this annual BIO5 event on Oct. 14 offered a space to exchange ideas across disciplines.

Hadassah Yosef will be working with the public affairs team at the BIO5 Institute in marketing, communications, and event planning.

The BIO5 Institute welcomes Gina Compitello back to the University of Arizona as its new director of communications, marketing, and public affairs, effective October 13, 2025.

BIO5 member Jennifer Barton at the University of Arizona received $3 million from the National Institute of Child Health and Human Development to develop a tiny imaging device that could revolutionize early detection of endometriosis and improve fertility care.

BIO5 member Clara Curiel-Lewandrowski and colleagues are developing synthetic wavelength imaging, a noninvasive optical technology to visualize skin cancers with greater depth and clarity. Supported by a $2.7M NIH award, the team aims to improve diagnosis and treatment precision.

BIO5 member Mohammed Hassan and an international team captured and controlled quantum uncertainty in real time using ultrafast pulses of light, marking the first demonstration of ultrafast squeezed light and paving the way for secure communication and ultrafast quantum technologies.

Dr. Maya Kaelberer and her research group focus on understanding how the gut senses and responds to the complex composition of food.

BIO5 member Jennifer Barton is leading an interdisciplinary team combining engineering, medicine, and imaging science to advance testing of the falloposcope, a device designed to detect ovarian cancer earlier and improve outcomes for high-risk patients.

On September 20, around 200 guests joined BIO5 for science and art activities for Wellness and Wonder Day 2025.

BIO5 member John Elfar and colleagues at the University of Arizona found that erythropoietin, a drug used for anemia, may speed healing in nerve crush injuries by boosting repair cells and clearing debris, offering a potential new treatment path